| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.507 | 45.651 | 57.839 | 60.062 | 82.233 | 78.995 | 70.212 |
| Total Income - EUR | - | - | - | 3.558 | 46.595 | 57.862 | 60.067 | 82.233 | 79.176 | 70.295 |
| Total Expenses - EUR | - | - | - | 7.221 | 51.520 | 55.912 | 68.260 | 81.475 | 59.148 | 61.614 |
| Gross Profit/Loss - EUR | - | - | - | -3.663 | -4.926 | 1.950 | -8.193 | 758 | 20.028 | 8.681 |
| Net Profit/Loss - EUR | - | - | - | -3.770 | -5.553 | 875 | -9.995 | -1.386 | 19.252 | 7.664 |
| Employees | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medvetico 29 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 6.748 | 8.910 | 7.476 | 6.073 | 4.851 | 3.599 | 4.012 |
| Current Assets | - | - | - | 6.525 | 6.076 | 19.155 | 18.081 | 2.636 | 2.949 | 5.698 |
| Inventories | - | - | - | 6.274 | 4.692 | 18.854 | 17.081 | 2.469 | 2.095 | 4.073 |
| Receivables | - | - | - | 0 | 9 | 37 | 36 | 60 | 4 | 131 |
| Cash | - | - | - | 251 | 1.375 | 264 | 963 | 107 | 851 | 1.494 |
| Shareholders Funds | - | - | - | -3.727 | -9.208 | -8.158 | -17.972 | -19.414 | -103 | 7.562 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 17.000 | 24.194 | 34.789 | 42.126 | 26.900 | 6.652 | 2.148 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Medvetico 29 S.r.l.